Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area gpcr g protein leukotriene receptor'

Search results for: 'research area gpcr g protein leukotriene receptor'

Items 41-50 of 52

Page
per page
  1. Fingolimod (FTY720)
    A8548 Fingolimod (FTY720)
    Target: S1P receptors
    Summary: S1P receptors agonist
  2. GNF-5837
    A8303 GNF-5837
    Target: Trk Receptors
    Summary: Pan-Trk inhibitor
      insoluble in EtOH; insoluble in H2O; ≥17 mg/mL
  3. IRAK-1-4 Inhibitor I
    A3505 IRAK-1-4 Inhibitor I
     3 Citation
    Target: IRAK
    Summary: IRAK-1/4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.75 mg/mL
  4. MGCD-265
    A5057 MGCD-265
    Target: VEGFR|c-MET
    Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor
      ≥25.9 mg/mL
  5. LOXO-101
    B6176 LOXO-101
    Target: tropomyosin receptor kinase
    Summary: tropomyosin receptor kinases (TRK) inhibitor
      ≥18.47 mg/mL
  6. Dovitinib (TKI-258, CHIR-258)
    A2168 Dovitinib (TKI-258, CHIR-258)
     2 Citation
    Target: FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Multitargeted RTK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥36.35 mg/mL
  7. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  8. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  9. AZD4547
    A8350 AZD4547
    Target: FGFR
    Summary: FGFR inhibitor
      ≥23.2 mg/mL
  10. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL

Items 41-50 of 52

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Axl 2item
  2. ALK 4item
  3. Broad Spectrum Protein Kinase Inhibitor 1 item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 4item
  7. c-RET 2item
  8. CSF-1R 1 item
  9. EGFR 7item
  10. EphB4 1 item
  11. FAK 4item
  12. FGFR 3item
  13. FLT3 2item
  14. HER2 3item
  15. IGF1R 3item
  16. IRAK 2item
  17. PDGFR 7item
  18. Pyk2 2item
  19. Spleen Tyrosine Kinase (Syk) 1 item
  20. Src 2item
  21. Tie-2 1 item
  22. Trk 3item
  23. VEGFR 11item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 2item
  3. CSF-1R 1 item
  4. FLT3 2item
  5. Eph Receptors 1 item
  6. VEGFR 13item
  7. PDGFR 9item
  8. c-Kit 6item
  9. RET 1 item
  10. IRAK 2item
  11. Bcr-Abl 2item
  12. FGFR 4item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 2item
  15. Src 1 item
  16. Trk Receptors 2item
  17. EGFR 5item
  18. FAK 4item
  19. BMP and Other Activin Receptors 3item
  20. Syk 1 item
  21. ErbB 2item
  22. c-MET 2item
  23. PKC 1 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  25. Lyn 1 item
  26. HER2 1 item
  27. Pyk2 3item
  28. S1P receptors 1 item
  29. Insulin and Insulin-like Receptors 2item
  30. PKG 1 item
  31. PKA 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. c-Fyn 1 item
  34. AXL 1 item
  35. c-Fms tyrosine kinase 1 item
  36. tropomyosin receptor kinase 1 item
Reported Experiments
  1. Animal Experiments 45item
  2. Cell Experiments 23item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 3item
  5. Breast Cancer 11item
  6. Cancer 39item
  7. Cervical Cancer 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Colon Cancer 1 item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 9item
  12. Glioblastoma 4item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 2item
  15. Liver Cancer 2item
  16. Lung Cancer 5item
  17. Lung Carcinoma 1 item
  18. Lymphoma 1 item
  19. Melanoma 2item
  20. Multiple Myeloma 4item
  21. Myeloma 1 item
  22. Non-small Cell Lung Cancer 4item
  23. Ovarian Cancer 5item
  24. Pancreatic Cancer 6item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cell Carcinoma 2item
  28. Thyroid Cancer 1 item